HomeCompareAMTI vs VIG

AMTI vs VIG: Dividend Comparison 2026

AMTI yields 760.46% · VIG yields 1.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMTI wins by $1810669.92M in total portfolio value
10 years
AMTI
AMTI
● Live price
760.46%
Share price
$0.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1810669.96M
Annual income
$1,438,546,236,154.04
Full AMTI calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →

Portfolio growth — AMTI vs VIG

📍 AMTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMTIVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMTI + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMTI pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMTI
Annual income on $10K today (after 15% tax)
$64,638.78/yr
After 10yr DRIP, annual income (after tax)
$1,222,764,300,730.93/yr
VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
At 15% tax rate, AMTI beats the other by $1,222,764,300,578.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMTI + VIG for your $10,000?

AMTI: 50%VIG: 50%
100% VIG50/50100% AMTI
Portfolio after 10yr
$905334.99M
Annual income
$719,273,118,166.60/yr
Blended yield
79.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VIG right now

AMTI
Analyst Ratings
3
Hold
2
Sell
Consensus: Hold
Price Target
$1.70
+546.4% upside vs current
Range: $0.40 — $3.00
Altman Z
-39.2
Piotroski
2/9
VIG
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMTI buys
0
VIG buys
0
No recent congressional trades found for AMTI or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMTIVIG
Forward yield760.46%1.64%
Annual dividend / share$2.00$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1810669.96M$32.4K
Annual income after 10y$1,438,546,236,154.04$179.15
Total dividends collected$1780986.19M$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: AMTI vs VIG ($10,000, DRIP)

YearAMTI PortfolioAMTI Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$86,746$76,045.63$11,304$163.92+$75.4KAMTI
2$709,325$616,507.07$12,759$166.33+$696.6KAMTI
3$5,470,398$4,711,420.77$14,382$168.52+$5.46MAMTI
4$39,811,308$33,957,981.79$16,192$170.52+$39.80MAMTI
5$273,562,787$230,964,686.86$18,210$172.34+$273.54MAMTI
6$1,775,955,421$1,483,243,239.55$20,460$173.98+$1775.93MAMTI
7$10,899,466,861$8,999,194,560.48$22,968$175.48+$10899.44MAMTI
8$63,279,465,088$51,617,035,546.83$25,763$176.83+$63279.44MAMTI
9$347,779,178,316$280,070,150,671.65$28,878$178.05+$347779.15MAMTI
10$1,810,669,956,952$1,438,546,236,154.04$32,350$179.15+$1810669.92MAMTI

AMTI vs VIG: Complete Analysis 2026

AMTIStock

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

Full AMTI Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this AMTI vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMTI vs SCHDAMTI vs JEPIAMTI vs OAMTI vs KOAMTI vs MAINAMTI vs DGROAMTI vs NOBLAMTI vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.